DAM
RNAM

DLD Asset Management’s Avidity Biosciences RNAM Stock Holding History

DLD Asset Management’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,200
Closed -$808K – 443
2025
Q4 		$808K Buy
+11,200
New +$723K 0.06% 200

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

DLD Asset Management's RNAM Position: Q1 2026 in Review

DLD Asset Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 11,200 shares — an estimated $808K sold.

DLD Asset Management first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $808K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • DLD Asset Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • DLD Asset Management sold 11,200 Avidity Biosciences shares in Q1 2026, an estimated $808K.
  • DLD Asset Management first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • DLD Asset Management's Avidity Biosciences position peaked at $808K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on DLD Asset Management's 13F filing for Q1 2026, filed 13 May 2026.